Liquidia (LQDA) Other Non-Current Assets (2019 - 2026)
Liquidia (LQDA) posted quarterly Other Non-Current Assets of $3.5 million for Q1 2026, down 77.45% year-over-year from $15.5 million in Q1 2025, and little changed quarter-over-quarter from $3.5 million in Q4 2025.
Liquidia (LQDA) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Liquidia's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 77.45% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (down 77.45% YoY), while the FY2025 annual figure was $3.5 million, down 67.91% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $3.5 million, roughly flat from $3.5 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $15.5 million in Q1 2025, with the low at $224000.0 in Q1 2024.
- The 5-year median for Other Non-Current Assets is $307000.0 (2022), against an average of $3.0 million.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets jumped 6838.39% in 2025, then plunged 77.45% in 2026.
- Liquidia's Other Non-Current Assets stood at $307000.0 in 2022, then dropped by 6.51% to $287000.0 in 2023, then jumped by 3704.18% to $10.9 million in 2024, then sank by 67.91% to $3.5 million in 2025, then changed by 0.0% to $3.5 million in 2026.
- Business Quant data shows LQDA's Other Non-Current Assets at $3.5 million in Q1 2026, $3.5 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Liquidia | 6.40 Bn | 6.11 Bn | 160.92 Mn | 19.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.31 Mn |
| Mar 31, 2026 | 3.50 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 15.54 Mn |
| Dec 31, 2024 | 10.92 Mn |
| Sep 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | 224,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Sep 30, 2023 | 287,000.00 |
| Jun 30, 2023 | 260,000.00 |
| Mar 31, 2023 | 307,000.00 |
| Dec 31, 2022 | 307,000.00 |
| Sep 30, 2022 | 307,000.00 |
| Jun 30, 2022 | 307,000.00 |
| Mar 31, 2022 | 307,000.00 |
| Dec 31, 2021 | 311,000.00 |
| Sep 30, 2021 | 312,925.00 |